ArticleNew Draft On Food Labeling Regulation Published2020 promises to be a very important year for food regulatory in China – at least for food labeling.ChinaFood, Drugs, Healthcare, Life SciencesHFG Law & Intellectual Property
ArticleUpcoming CFDA Inspection On Class I And Class II Medical Devices ManufacturersCircular (2014) No.15 provides for the specific deadlines for different domestic medical devices manufacturing companies to gradually meet the Medical Devices Manufacturing Quality Management StandardsChinaFood, Drugs, Healthcare, Life SciencesCMS Cameron McKenna Nabarro Olswang
ArticleChinese Customs Creates Registration Requirement For Companies Involved In Food ImportOn April 12, 2021, the General Administration of Customs (GAC) of the People's Republic of China (PRC or China) released two orders related to the import of food products into China...ChinaInternational LawWinston Taylor
ArticleCFDA Solicits Comments On Drug Registration RulesUnlike the DRR, the Revisions do not distinguish an international multicenter study from a drug registration study. ChinaFood, Drugs, Healthcare, Life SciencesRopes & Gray LLP
ArticleChina Announces Final Biosimilars GuidelineThe Center for Drug Evaluation (the "CDE") under the China Food and Drug Administration published final biosimilars guidance on February 28 with immediate effect.ChinaFood, Drugs, Healthcare, Life SciencesRopes & Gray LLP
ArticleChina’s Drug Trial Data Protection Regime Is Now Formally In ForceChina's National Medical Products Administration has officially implemented new drug trial data protection measures, establishing a comprehensive framework that grants varying protection periods based on innovation levels. ChinaFood, Drugs, Healthcare, Life SciencesLusheng Law Firm
ArticlePRC Food Safety Law: Food for ThoughtConsultations during recent NPC and CPPCC sessions regarding food safety aimed to further promote institutional reform.ChinaFood, Drugs, Healthcare, Life SciencesKing & Wood Mallesons
Article중국 국가지식산권국 등, 의약품 집중 구매 분야의 지식재산권 보호 강화에 관한 의견 발표2022년 12월 5일, 중국 국가지식산권국(CNIPA) 및 국가의료보장국은 ‘의약품 집중 구매분야의 지식재산권 보호 강화에 관한 의견'2)을 공동 발표함...ChinaGovernment, Public SectorKangxin
ArticleChina Promulgates Fourth Amendment To Patent LawOn October 17, 2020, the Standing Committee of the National People's Congress in China promulgated the fourth amended Patent Law of the People's Republic of ChinaChinaIntellectual PropertyJones Day
ArticleFood Investors May Be Biting Off More Than They Can ChewAsia's meat, dairy and seafood companies are booming, with many investors regarding them as a smart play on rising middle-class income in the region. ChinaCorporate/Commercial LawICSA
ArticleChina FDA Solicits Comments On Conditional Approvals For New Drugs And Compassionate Use Of Investigational DrugsThe CFDA is soliciting public comments for these drafts until mid-January 2018. ChinaFood, Drugs, Healthcare, Life SciencesRopes & Gray LLP
ArticleAn Overview Of The Latest Amendment To The Chinese Patent LawThe Fourth Amendment to the Chinese patent law will become effective on June 1, 2021. The Patent Law of the People's Republic of China, originally established in 1985...ChinaIntellectual PropertyFinnegan, Henderson, Farabow, Garrett & Dunner LLP
ArticleChina's Latest Patent Law Amendment Introduces Patent Linkage And Patent Term ExtensionOn July 3, 2020, the Standing Committee of the National People's Congress published the second draft amendment to the Patent Law (the "Second Draft Amendment"), soliciting public...ChinaIntellectual PropertyRopes & Gray LLP
ArticleChina's Latest Patent Law Amendment Introduces Patent Linkage, Patent Term Extension, And Patent Term AdjustmentOn July 3, 2020, the Standing Committee of the National People's Congress published the second draft amendment to the Patent Law (the "Second Draft Amendment"), ...ChinaIntellectual PropertyRopes & Gray LLP
ArticleInsight Into Recent PRB Decisions On Pharmaceutical /Biotech InventionsThe Patent Reexamination Board (hereinafter referred to as the PRB) is an organization under the SIPO (State Intellectual Property Office) of China.ChinaIntellectual PropertyWan Hui Da - Peksung IP Group
ArticleNMPA And CNIPA Issued Measures For The Implementation Of Early Resolution Mechanisms For Drug Patent Disputes On July 4, 2021The generics applicant, when filing a request for drug marketing approval, shall make a declaration on each relevant drug patent.ChinaIntellectual PropertyIP March
ArticlePatent Portfolio Of Remdesivir - Potential Drug For Novel CoronavirusThe new coronavirus epidemic is becoming increasingly serious. As of February 21, 2020, the number of people infected with new coronavirus nationwide exceeded 70,000,...ChinaIntellectual PropertyKangxin
ArticlePatent Term Extension In ChinaIn China, since 1993 the term of a patent for invention (equivalent to utility patent) has been 20 years.ChinaIntellectual PropertyCCPIT Patent and Trademark Law Office
ArticleThe impact of the amended PRC Advertising Law on health-related advertisementsThe New Advertising Law strongly regulates advertisements of healthcare, medications, medical devices, and health food. ChinaMedia, Telecoms, IT, EntertainmentKing & Wood Mallesons